Skip to content
Search

Latest Stories

Submit Guest Post

India-produced Covid vaccine receives emergency approval: WHO

India-produced Covid vaccine receives emergency approval: WHO

The World Health Organization on Friday announced it has granted emergency approval to the India-manufactured coronavirus vaccine Covovax.

The jab, produced by Serum Institute of India under licence from the US-based Novavax, will now be distributed as part of global vaccine-sharing system Covax, "giving a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries", WHO said in a statement.


"Even with new variants emerging, vaccines remain one of the most effective tools to protect people against serious illness and death from SARS-COV-2," said Mariangela Simao, the WHO's access to vaccines chief.

"This listing aims to increase access particularly in lower-income countries, 41 of which have still not been able to vaccinate 10 percent of their populations, while 98 countries have not reached 40 percent," she said.

Covovax requires two doses and is stable at 2 to 8 degrees Celsius refrigerated temperatures.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Cipla's Yusuf Hamied helps modernise Cambridge chemistry labs

Yusuf Hamied and Jeremy Sanders during the opening of the chemistry labs in Cambridge on Friday (31)

Amit Roy

Cipla's Yusuf Hamied helps modernise Cambridge chemistry labs

Amit Roy

Dr Yusuf Hamied was in a nostalgic mood at the formal inauguration of two laboratories in the department of chemistry at Cambridge University which have been completely refurbished and modernised with his financial help.

“I’m just happy to be here,” said the head of Cipla, the Indian pharma giant, at the function which took place on Friday (31).

Keep ReadingShow less